Liposomal NMN ibiologic inobatanidza liposome teknolojia neNMN (niacin mononucleotide). NMN chinhu chinokwanisa kurwisa kuchembera uye chinofungidzirwa kuti chinovandudza masero emagetsi metabolism, kuwedzera simba resero uye kudzivirira maseru kubva mukushushikana kweiyo oxidative. Liposomes zvimedu zvinoumbwa nekaviri-layered lipid chimiro chakafanana neicho chesero membrane, chinogona kubatsira kunyungudutsa uye kutora mishonga, nekudaro kuvandudza kwavo bioavailability. Encapsulating NMN mu liposomes inovandudza kugadzikana uye bioavailability yeNMN uye inoita kuti zvive nyore kutorwa nemasero. Liposome NMN inotendwa kuti ine zvinotevera zvakanakira: Kuvandudza kunyura zvakanaka: Nekuiputira mu liposomes, kunyungudika uye kugadzikana kweNMN kunogona kuvandudzwa, nekudaro kunowedzera kunyura mumasero. Kuwedzera bioavailability: Liposomes inogona kubatsira NMN kuyambuka maseru membranes zviri nani, kuvandudza bioavailability yayo uye ichibvumira kuti ishande zvakanyanya. Inopa dziviriro: Liposomes inogona kudzivirira NMN kubva mukukuvadzwa neacidic gastric juices uye mamwe ma enzymes ekudya, nokudaro kuwedzera kugadzikana kwayo uye bioavailability mumatumbo. Kazhinji, liposomal NMN inhengo yebhayoloji inosanganisa liposome tekinoroji neNMN. Nekuvandudza kugadzikana uye bioavailability yeNMN, inogona kuita zvirinani maitiro ekurwisa kuchembera eNMN, kukurudzira hutano hwesero uye hutano.
Benefits ofNMN Powder
Liposome NMN inotendwa kuti ine zvinotevera zvakanakira: Kuvandudza kunyura zvakanaka: Nekuiputira mu liposomes, kunyungudika uye kugadzikana kweNMN kunogona kuvandudzwa, nekudaro kunowedzera kunyura mumasero. Kuwedzera bioavailability: Liposomes inogona kubatsira NMN kuyambuka maseru membranes zviri nani, kuvandudza bioavailability yayo uye ichibvumira kuti ishande zvakanyanya. Inopa dziviriro: Liposomes inogona kudzivirira NMN kubva mukukuvadzwa neacidic gastric juices uye mamwe ma enzymes ekudya, nokudaro kuwedzera kugadzikana kwayo uye bioavailability mumatumbo. Kazhinji, liposomal NMN inhengo yebhayoloji inosanganisa liposome tekinoroji neNMN. Nekuvandudza kugadzikana uye bioavailability yeNMN, inogona kuita zvirinani maitiro ekurwisa kuchembera eNMN, kukurudzira hutano hwesero uye hutano.
Analysis Items | Zvinotsanangurwa | Nzira |
Active Ingredients Miedzo | ||
NMN Kuongorora (HPLC) | ≥99.0% | T/CASME 012-2021 |
NMN Kuchena (HPLC) | 98.00%-101.00% | T/CASME 012-2021 |
Miedzo Yomuviri | ||
Chitarisiko | Pepodha | Visual |
Kuravira & kunhuwa | Szvedukuravira | Organoleptic |
pH kukosha | 3.0-4.0 | GB 5009.237 |
Bulk density | 0.30-0.65g/mL | GB 5009.2 |
Hunyoro hwemukati | ≤0.50% | GB 5009.3 |
Madota zviri mukati | ≤0.50% | GB 5009.4 |
Chemical Tests | ||
Heavy Metals | ≤10.00ppm | GB 5009.74 |
Pb | ≤0.10ppm | GB 5009.12 |
AsArsenic> | ≤0.10ppm | GB 5009.11 |
Cd | ≤0.20ppm | GB 5009.15 |
Hg | ≤0.10ppm | GB 5009.17 |
Potassium | ≤100ppm | GB 5009.91 |
Sruvengo | ≤100ppm | GB 5009.91 |
Solvent residual(Ethanol) | ≤1,000ppm | GB 5009.262 |
Miedzo yeMicrobiological | ||
Total UtachionalCountts | ≤1,000cfu/g | GB 4789.2 |
Mbiriso uye Molds | ≤25cfu/g | GB 4789.15 |
Coliform | 50MPN/100g | GB 4789.3 |
E. Coli | Negative mu1g | GB 4789.38 |
Salmonella | Negative mu10g | GB 4789.4 |
Staphylococcus aureus | Negative mu1g | GB 4789.10 |
Bacterial endotoxin | ≤0.5EU/mg | Ch.P2020 IV |
* Mashoko:Irradiatedyemahara, GMO yemahara, Zvinowedzerwa zvemahara,Allergen Yemahara. |
★ Kambani ine 800,000㎡chigadziko chekurima muInner Monglia.
★ Spirulina poda uye inobvisa inotengeswa kunze kwenyika dzinopfuura makumi matanhatu.
★ Microcystic chepfu Yemahara, PAHs inokodzera uye ETO Yemahara.
★ Zvigadzirwa zvakamira, mutengo unonzwisisika, basa rehunyanzvi rinoramba richipihwa.